Trial Profile
Efficacy of ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 27 Jun 2016 New trial record
- 16 Jun 2016 Primary endpoint of in-hospital halving of plasma NT-proBNP levels has been met, according to results published in the Clinical Drug Investigation.
- 16 Jun 2016 Results published in the Clinical Drug Investigation